MedPath

Omega 3 Lipid Emulsions and Liver Transplantation

Not Applicable
Conditions
Ischemia Re-perfusion Injury
Registration Number
NCT01957943
Lead Sponsor
Mansoura University
Brief Summary

The study Aims to investigate the possible beneficial impact of peri-operative or post-operative administration of Omega 3 enriched lipid emulsions on recipients for living donor liver transplantation.

Detailed Description

Patients will be divided intro three groups, A control group will receive equivalent volume of glucose 10% solution both 3 days before and 5 days after the operation .

A peri-operative groups, in which patients will receive omega 3 enriched lipid emulsion (SMOFLipid) for 2 days pre-transplantation and 5 days post-transplantation A Post-operative group, in which patients will receive glucose 10% 3 days before the operation and omega 3 enriched lipid emulsion (SMOFLipid) for 5 days post-transplantation The primary outcome objective will be the incidence of Ischemia re-perfusion injury, secondary outcomes includes post-operative complications, graft and patient's outcomes and graft regeneration

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
114
Inclusion Criteria
  • All liver transplant recipients
Exclusion Criteria
  • Budd chiari
  • Previous upper abdominal surgery
  • Re-transplantation
  • Known allergy to the study emulsion

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Ischemia reperfusion injury5 days
Secondary Outcome Measures
NameTimeMethod
Liver functions5 days
Late graft regeneration3 month

assessment of percent of liver regeneration 13 months PO

Early graft regenerationone month

assessment of percent of liver regeneration 1 month PO

Trial Locations

Locations (1)

Liver transplantation program - Gastroenterology surgical center - Mansoura university

🇪🇬

Mansoura, Dakahlia, Egypt

Liver transplantation program - Gastroenterology surgical center - Mansoura university
🇪🇬Mansoura, Dakahlia, Egypt
Amr M Yassen, MD
Contact
+201001497044
amryassen@hotmail.com
waleed R elsarraf, MD
Contact
+201222322727
welsarraf@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.